Literature DB >> 19641242

In vivo imaging of irreversible electroporation by means of electrical impedance tomography.

Yair Granot1, Antoni Ivorra, Elad Maor, Boris Rubinsky.   

Abstract

Electroporation, the increased permeability of cell membranes due to a large transmembrane voltage, is an important clinical tool. Both reversible and irreversible in vivo electroporation are used for clinical applications such as gene therapy and solid malignant tumor ablation, respectively. The primary advantage of in vivo electroporation is the ability to treat tissue in a local and minimally invasive fashion. The drawback is the current lack of control over the process. This paper is the first report of a new method for real-time three-dimensional imaging of an in vivo electroporation process. Using two needle electrodes for irreversible electroporation and a set of electrodes for reconstructing electrical impedance tomography (EIT) images of the treated tissue, we were able to demonstrate electroporation imaging in rodent livers. Histology analysis shows good correlation between the extent of tissue damage caused by irreversible electroporation and the EIT images. This new method may lead the way to real-time control over genetic treatment of diseases in tissue and tissue ablation.

Entities:  

Mesh:

Year:  2009        PMID: 19641242     DOI: 10.1088/0031-9155/54/16/006

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  16 in total

Review 1.  A brief overview of electroporation pulse strength-duration space: a region where additional intracellular effects are expected.

Authors:  James C Weaver; Kyle C Smith; Axel T Esser; Reuben S Son; T R Gowrishankar
Journal:  Bioelectrochemistry       Date:  2012-03-14       Impact factor: 5.373

2.  Targeted gene-and-host progenitor cell therapy for nonunion bone fracture repair.

Authors:  Nadav Kimelman-Bleich; Gadi Pelled; Yoram Zilberman; Ilan Kallai; Olga Mizrahi; Wafa Tawackoli; Zulma Gazit; Dan Gazit
Journal:  Mol Ther       Date:  2010-09-21       Impact factor: 11.454

3.  Diffusion-weighted MRI for verification of electroporation-based treatments.

Authors:  Faisal Mahmood; Rasmus H Hansen; Birgit Agerholm-Larsen; Kurt S Jensen; Helle K Iversen; Julie Gehl
Journal:  J Membr Biol       Date:  2011-03-06       Impact factor: 1.843

4.  Recent advances in focal therapy of prostate and kidney cancer.

Authors:  Matvey Tsivian; Thomas J Polascik
Journal:  F1000 Med Rep       Date:  2010-01-18

5.  Rapid Impedance Spectroscopy for Monitoring Tissue Impedance, Temperature, and Treatment Outcome During Electroporation-Based Therapies.

Authors:  Melvin F Lorenzo; Suyashree P Bhonsle; Christopher B Arena; Rafael V Davalos
Journal:  IEEE Trans Biomed Eng       Date:  2021-04-21       Impact factor: 4.538

6.  Real-time impedance feedback to enhance cutaneous gene electrotransfer in a murine skin model.

Authors:  Reginald M Atkins; Timothy J Fawcett; Richard Gilbert; Andrew M Hoff; Richard Connolly; Douglas W Brown; Mark J Jaroszeski
Journal:  Bioelectrochemistry       Date:  2021-07-13       Impact factor: 5.373

7.  Ex vivo and in silico feasibility study of monitoring electric field distribution in tissue during electroporation based treatments.

Authors:  Matej Kranjc; Franci Bajd; Igor Sersa; Eung Je Woo; Damijan Miklavcic
Journal:  PLoS One       Date:  2012-09-20       Impact factor: 3.240

8.  Current and future technology for minimally invasive ablation of renal cell carcinoma.

Authors:  Branden G Duffey; J Kyle Anderson
Journal:  Indian J Urol       Date:  2010-07

9.  Non-thermal irreversible electroporation (N-TIRE) and adjuvant fractionated radiotherapeutic multimodal therapy for intracranial malignant glioma in a canine patient.

Authors:  P A Garcia; T Pancotto; J H Rossmeisl; N Henao-Guerrero; N R Gustafson; G B Daniel; J L Robertson; T L Ellis; R V Davalos
Journal:  Technol Cancer Res Treat       Date:  2011-02

10.  The optimization of needle electrode number and placement for irreversible electroporation of hepatocellular carcinoma.

Authors:  Oyinlolu O Adeyanju; Haitham M Al-Angari; Alan V Sahakian
Journal:  Radiol Oncol       Date:  2012-04-19       Impact factor: 2.991

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.